Immunoregulation in cutaneous allergy – prevention and control
66. | Zielinski, C., Zuberbier, T., and Maurer, M.: Immunoregulation in cutaneous allergy – prevention and control. Curr. Opin. Allergy Clin. Immunol. 2012: 12; 498-503. IF: 3.39 |
Found 522 hits.
66. | Zielinski, C., Zuberbier, T., and Maurer, M.: Immunoregulation in cutaneous allergy – prevention and control. Curr. Opin. Allergy Clin. Immunol. 2012: 12; 498-503. IF: 3.39 |
64. | Krause, K., Metz, M., Makris, M., Zuberbier, T., and Maurer, M.: The role of Interleukin-1 in allergy-related disorders. Curr. Opin. Allergy Clin. Immunol. 2012: 12; 477-484. IF: 3.39 |
52. | Maurer, M., Weller, K., Bindslev-Jensen, C., Giménez-Arnau, A., Bousquet, P., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E. J., Greaves, M. W., Hide, M., Kalogeromitros, D., Kaplan, A. P., Saini, S. S., Zhu, X. J., and Zuberbier, T.: Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy 2011: 66; 317-330. IF: 6.27 |
r.052
197 | Rogala, B., Bozek, A.+, Glück, J., Rymarczyk, B., Jarzab, J., and Maurer, M.: Coexistence of angioedema alone with impaired glucose tolerance. Int. Arch. Allergy Immunol. 2014: 165; 265-269. IF: 2.67 |
o.197
200 | Kay, A. B.+, Ying, S., Ardelean, E., Młynek, A., Kita, H., Clark, P., and Maurer, M.: Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low level persistence in uninvolved skin. Brit. J. Dermatol. 2014: 171; 505-511. IF: 4.27 |
107 | Altrichter, S., Peter, H.-J., Pisarevskaja, D., Metz, M., Martus, P., and Maurer, M.+: IgE mediated autoallergy against thyroid peroxidase – a novel pathomechanism of chronic spontaneous urticaria? PLoS ONE 2011: 6; e14794. IF: 4.09 |
o.107
348 | Bonnekoh, H., Scheffel, J., Wu, J., Hoffmann, S., Maurer, M., and Krause, K.+: Skin and systemic inflammation in Schnitzler’s syndrome are associated with neutrophil extracellular trap formation. Front. Immunol. 2019: 10; 546. IF: 5.08 |
o.348
279 | Aberer, W.+, Maurer, M. Bouillet, L., Zanichelli, A., Caballero, T., Longhurst, H. J., Perrin, A., and Andresen, I.: Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the icatibant outcome survey. Allerg. Asthma Clin. Immunol. 2017: 13; 31. IF: 2.05 |
278 | Caballero, T. + Aberer, W., Longhurst, H. J., Maurer, M. Zanichelli, A., Perrin, A., Bouillet, L., and Andresen, I.: The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 1214-1222. IF: 4.29 |
212 | Hernández Fernández de Rojas, D.+, Ibáňez, E., Longhurst, H., Maurer, M. Fabien, V., Aberer, W., Bouillet, L., Zanichelli, A., and Caballero, T.: Treatment of HAE attacks in the icatibant outcome survey: an analysis of icatibant self-administration versus administration by health care professionals. Int. Arch. Allergy Immunol. 2015: 167; 21-28. IF: 2.67 |